Immutep Limited ADR (IMMP): Next-Year EPS Estimate 45.03%
As of 2026-06-04, Immutep Limited ADR (IMMP) has a next-year EPS growth estimate of 45.03%.
On 2026-05-03, analyst consensus for IMMP's next-year EPS growth shifted from 42.60% to 45.03% — a positive change of 2.43 percentage points. The revised estimate has been sustained across 25 subsequent trading sessions. Current-year growth is projected at -16.16%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 45.03%
- EPS growth this year
- -16.16%
- EPS next quarter (est)
- -$0.04
- Last price
- $0.39
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 45.03% | -16.16% | -$0.04 | $0.39 |
| 2026-06-03 | 45.03% | -16.16% | -$0.04 | $0.41 |
| 2026-06-02 | 45.03% | -16.16% | -$0.04 | $0.42 |
| 2026-06-01 | 45.03% | -16.16% | -$0.04 | $0.40 |
| 2026-05-31 | 45.03% | -16.16% | -$0.04 | $0.44 |
| 2026-05-28 | 45.03% | -16.16% | -$0.04 | $0.44 |
| 2026-05-27 | 45.03% | -16.16% | -$0.04 | $0.43 |
| 2026-05-26 | 45.03% | -16.16% | -$0.04 | $0.45 |
| 2026-05-25 | 45.03% | -16.16% | -$0.04 | $0.49 |
| 2026-05-24 | 45.03% | -16.16% | -$0.03 | $0.49 |
| 2026-05-21 | 45.03% | -16.16% | -$0.03 | $0.48 |
| 2026-05-20 | 45.03% | -16.16% | -$0.03 | $0.47 |
| 2026-05-19 | 45.03% | -16.16% | -$0.03 | $0.50 |
| 2026-05-18 | 45.03% | -16.16% | -$0.03 | $0.49 |
| 2026-05-17 | 45.03% | -16.16% | -$0.03 | $0.52 |
| 2026-05-14 | 45.03% | -16.16% | -$0.03 | $0.45 |
| 2026-05-13 | 45.03% | -16.16% | -$0.03 | $0.46 |
| 2026-05-12 | 45.03% | -16.16% | -$0.03 | $0.47 |
| 2026-05-11 | 45.03% | -16.16% | -$0.03 | $0.44 |
| 2026-05-10 | 45.03% | -16.16% | -$0.03 | $0.45 |
| 2026-05-07 | 45.03% | -16.16% | -$0.03 | $0.43 |
| 2026-05-06 | 45.03% | -16.16% | -$0.03 | $0.44 |
| 2026-05-05 | 45.03% | -16.16% | -$0.03 | $0.46 |
| 2026-05-04 | 45.03% | -16.16% | -$0.03 | $0.46 |
| 2026-05-03 | 45.03% | -16.16% | -$0.03 | $0.44 |
| 2026-04-30 | 42.60% | -4.42% | -$0.03 | $0.46 |
| 2026-04-29 | 42.60% | -4.42% | -$0.03 | $0.48 |
| 2026-04-28 | 42.60% | -4.42% | -$0.03 | $0.49 |
| 2026-04-27 | 42.60% | -4.42% | -$0.03 | $0.52 |
| 2026-04-26 | 42.60% | -4.42% | -$0.03 | $0.57 |
Recent News
- Lost Money on Immutep Limited (IMMP)? Possible Fraud - Contact Levi & Korsinsky TodayNewsfile
- Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune DiseasesGlobeNewswire
- Immuteps LAG-3 hopes take a hit on Phase III NSCLC terminationClinical Trials Arena
- Adobe downgraded, Nio upgraded: Wall Street's top analyst callsThe Fly
- TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility AnalysisGlobeNewswire
- Evotec, Vistagen lay off staff; Immutep shares collapse on study failureBioPharma Dive
- Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLCGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Immutep Limited ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Immutep Limited ADR (IMMP) has a next-year EPS growth estimate of 45.03%, based on analyst consensus.
When was the latest EPS estimate revision for IMMP?▾
The most recent revision occurred on 2026-05-03, when analysts adjusted the next-year EPS growth estimate from 42.60% to 45.03%.
What sector and industry does Immutep Limited ADR belong to?▾
Immutep Limited ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IMMP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Immutep Limited ADR (IMMP) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports